Jefferies & Company
JEF
$45.25
-1.05%
Jefferies Financial Group Inc. is a full-service investment banking and capital markets firm operating in the Financial Services sector, primarily serving the North American middle market with advisory, underwriting, sales and trading, and asset management services. Founded in 1962 and publicly listed since 1968, the firm has evolved from an institutional trading house into a diversified investment bank after its 2013 merger with Leucadia National, which transformed it into a holding company that has since divested most legacy non-financial assets. Jefferies is distinct as one of the few independent, non-bulge-bracket investment banks that has consistently gained market share from larger competitors, particularly in mid-cap M&A advisory and leveraged finance. The current investor narrative centers on the firm's ability to sustain record investment banking revenues amid a volatile capital markets backdrop, with recent quarterly results showing strong year-over-year revenue growth driven by advisory and underwriting activity, while simultaneously navigating elevated interest expenses and a challenging operating environment that has pressured profitability metrics.…
JEF
Jefferies & Company
$45.25
Related headlines
Investment Opinion: Should I buy JEF Today?
Based on the synthesis of analyst consensus, valuation metrics, and growth trajectory, the recommendation is a Hold with a bias toward accumulation on weakness. The core thesis is that Jefferies is a well-positioned middle-market investment bank trading at a discounted forward PE of 10.71x, but near-term headwinds from margin compression and a recent analyst downgrade warrant caution. The analyst consensus rating of 'buy' (mean 2.33) and average target price of $59.50 imply a 24.8% upside, but the wide target range of $46.00 to $76.00 reflects significant uncertainty. The stock's 27.68% decline over the past year has created a value opportunity, but the lack of a near-term catalyst and the technical downtrend suggest patience is required.
Supporting evidence for a Hold includes the robust revenue growth of 36.74% year-over-year in Q2 2026, driven by investment banking and underwriting activities, which demonstrates the firm's ability to capture market share. The forward PE of 10.71x is significantly below the trailing PE of 19.43x and the sector average, implying that the market expects substantial earnings growth, with estimated EPS of $5.04 for the forward year. The price-to-book ratio of 1.16x is near historical lows and below the sector average of 1.3x-1.5x, providing a margin of safety. Additionally, the dividend yield of 3.05% with a payout ratio of 52.66% offers income support, and the free cash flow of $1.78 billion TTM underscores financial flexibility. However, the net margin of 7.49% remains below the 15-20% range of bulge-bracket peers, and the return on equity of 6.72% is modest.
The biggest risks that could invalidate the thesis include a sustained decline in capital markets activity, which would pressure investment banking revenues, and further margin erosion due to elevated interest expenses. A breach of the 52-week low of $35.53 could trigger a deeper sell-off, especially given the high beta of 1.491. The rating would upgrade to Buy if the forward PE compresses below 10x while revenue growth remains above 20%, or if the stock breaks above resistance at $69.93. Conversely, a downgrade to Sell would occur if revenue growth decelerates below 10% or if net margin falls below 6%. Relative to its history and peers, the stock appears undervalued on a forward earnings and book value basis, but the market is pricing in significant risks that must be monitored.
Sign up to view all
JEF 12-Month Price Forecast
The forward-looking view is neutral with medium confidence, as the company's strong revenue growth and discounted forward valuation are offset by margin pressure, high leverage, and technical weakness. The base case (55% probability) targets $55-$62, reflecting steady execution and gradual recovery toward the analyst average. The bull case (25%) hinges on a capital markets rebound and margin expansion, while the bear case (20%) risks a retest of the 52-week low if deal activity stalls. I would upgrade to bullish if net margin stabilizes above 8% and revenue growth remains above 20%, or downgrade to bearish if the stock breaks below $40 with deteriorating fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Jefferies & Company's 12-month outlook, with a consensus price target around $55.83 and implied upside of +23.4% versus the current price.
Average Target
$55.83
0 analysts
Implied Upside
+23.4%
vs. current price
Analyst Count
—
covering this stock
Price Range
$47 - $71
Analyst target range
Six analysts cover Jefferies, with a consensus recommendation of "buy" and a recommendation mean of 2.33 (where 1 is strong buy and 5 is strong sell), indicating a moderately bullish sentiment. The average target price is $59.50, which implies a 24.8% upside from the current price of $47.68. The consensus leans bullish, with the average target well above the current price, though the recommendation mean of 2.33 suggests some analysts are more neutral than outright bullish. The estimated EPS average of $5.04 for the forward year, if achieved, would represent a dramatic improvement from the trailing EPS of $0.058, supporting the optimistic target prices.
The target price range spans from a low of $46.00 to a high of $76.00, a spread of $30.00 or 65% of the low target, indicating significant disagreement among analysts about the company's prospects. The high target of $76.00 assumes a successful execution of growth initiatives, multiple expansion, and continued strength in investment banking revenues, potentially driven by a rebound in M&A and capital markets activity. The low target of $46.00, which is slightly below the current price, prices in margin compression, competitive pressures, or a broader market downturn that could impair Jefferies' earnings power. Recent institutional ratings show a mix of actions: UBS downgraded from Buy to Neutral on June 18, 2026, while Oppenheimer maintained Outperform and Goldman Sachs maintained Buy, suggesting that while some analysts are turning cautious, others remain constructive on the stock's long-term potential. The wide target spread signals high uncertainty, and the recent downgrade by UBS may indicate shifting sentiment that could pressure the stock in the near term.
Bulls vs Bears: JEF Investment Factors
The bear case currently has stronger evidence due to the stock's severe underperformance (-27.68% 1-year return), margin compression, and recent analyst downgrade, which collectively signal deteriorating investor confidence. However, the bull case is underpinned by robust revenue growth (+36.74% YoY), a deeply discounted forward PE of 10.71x, and a consensus target implying 24.8% upside, suggesting the market may be overly pessimistic. The single most important tension is whether Jefferies can sustain its investment banking revenue momentum amid a volatile capital markets environment; if it does, the forward earnings estimate of $5.04 could drive a significant re-rating, but any slowdown could validate the bearish technical trend and push the stock toward its 52-week low.
Bullish
- Revenue growth accelerating sharply: Q2 2026 revenue of $3.41 billion grew 36.74% year-over-year from $2.49 billion in Q2 2025, marking the strongest growth rate in recent quarters. This acceleration is driven by investment banking revenue of $1.21 billion, reflecting market share gains in advisory and underwriting.
- Forward PE implies deep undervaluation: The forward PE of 10.71x is significantly below the trailing PE of 19.43x and the sector average of 12x-18x for capital markets firms. This 44.9% earnings growth expectation, if realized, suggests the stock is priced for pessimism despite record revenue.
- Strong free cash flow generation: Jefferies generated $1.78 billion in trailing twelve-month free cash flow and $1.59 billion in operating cash flow in Q2 2026 alone. This robust cash generation supports the 3.05% dividend yield and a sustainable 52.66% payout ratio.
- Analyst consensus target implies upside: The average analyst target price of $59.50 represents a 24.8% upside from the current price of $47.68, with a consensus recommendation of 'buy' (mean 2.33). The high target of $76.00 suggests potential for a 59.4% gain if growth initiatives succeed.
Bearish
- Severe relative underperformance: The stock has declined 27.68% over the past year, vastly underperforming the S&P 500's +17.22% return, resulting in a relative strength of -44.90%. This persistent weakness suggests deep-rooted investor skepticism about the company's prospects.
- Margin compression evident: Net margin declined to 7.49% in Q2 2026 from 8.69% in Q3 2025 and 8.14% in Q4 2024, despite revenue growth. Interest expenses of $911.7 million and operating expenses of $1.89 billion are pressuring profitability.
- High leverage and modest ROE: The debt-to-equity ratio of 2.25 is elevated, and return on equity of 6.72% lags the 10-12% typical for investment banking peers. This limits the firm's ability to generate shareholder value through retained earnings.
- Recent analyst downgrade and wide target spread: UBS downgraded the stock from Buy to Neutral on June 18, 2026, and the analyst target range spans $46.00 to $76.00, a 65% spread. This high uncertainty reflects divergent views on the sustainability of recent revenue growth.
JEF Technical Analysis
Jefferies is in a sustained downtrend over the trailing twelve months, with a 1-year price change of -27.68% and a year-to-date decline of -24.87%, significantly underperforming the S&P 500's +17.22% 1-year return. At the current price of $47.68, the stock sits at approximately 35.4% of its 52-week range (52-week low of $35.53 and high of $69.93), placing it in the lower-middle portion of its annual trading band. This positioning suggests the stock is neither at a capitulation low nor showing momentum strength, but rather languishing in a corrective phase that has erased a substantial portion of prior gains. The relative strength versus SPY over 1 year is -44.90%, underscoring severe underperformance and raising the question of whether this represents a value opportunity or a falling knife scenario.
Short-term momentum has deteriorated sharply, with a 1-month price change of -10.26% and a 3-month change of -2.89%, indicating that the recent selling pressure has accelerated. This 1-month decline diverges from the 6-month gain of +19.65%, suggesting that the stock experienced a strong rally through mid-2026 before reversing course dramatically in the past month. The 1-month relative strength versus SPY is -10.95%, meaning Jefferies has underperformed the broader market by nearly 11 percentage points in just one month, a significant divergence that signals deteriorating investor confidence. The recent price action from a June high of $62.81 down to the current $47.68 represents a drawdown of approximately 24% from that peak, and the stock's beta of 1.491 indicates it amplifies market moves by roughly 49%, making this decline particularly pronounced.
Key technical support is anchored at the 52-week low of $35.53, which represents a critical floor that, if breached, could trigger further downside toward unknown territory. Resistance is established at the 52-week high of $69.93, and a breakout above this level would signal a complete trend reversal and renewed bullish momentum. The maximum drawdown of -48.81% over the observed period highlights the stock's vulnerability to sharp reversals, and with a beta of 1.491, position sizing should account for the stock's heightened volatility relative to the broader market. The current price of $47.68 is only 34% above the 52-week low, suggesting limited downside cushion before testing those lows, while the 52-week high remains 46.7% above current levels, indicating substantial upside potential if sentiment reverses.
Beta
1.49
1.49x market volatility
Max Drawdown
-48.8%
Largest decline past year
52-Week Range
$36-$67
Price range past year
Annual Return
-28.7%
Cumulative gain past year
| Period | JEF Return | S&P 500 |
|---|---|---|
| 1m | -12.9% | +0.3% |
| 3m | -14.0% | +2.6% |
| 6m | +8.6% | +16.5% |
| 1y | -28.7% | +14.3% |
| ytd | -28.7% | +12.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
JEF Fundamental Analysis
Jefferies' revenue trajectory has been robust, with the most recent quarter (Q2 2026, ending May 31, 2026) reporting revenue of $3.41 billion, representing a 36.74% year-over-year increase from $2.49 billion in Q2 2025. This growth is part of a multi-quarter uptrend, with Q1 2026 revenue of $2.87 billion and Q4 2025 revenue of $2.95 billion, both showing sequential and annual improvements. The revenue segment breakdown reveals that investment banking generated $1.21 billion, interest revenue contributed $854 million, and principal transactions added $489 million, with commissions and other fees at $401 million, indicating a diversified revenue base led by advisory and underwriting activities. The strong YoY growth suggests Jefferies is capturing market share and benefiting from a rebound in capital markets activity, though the sustainability of this growth depends on the broader deal-making environment.
Profitability remains positive but faces margin pressure, with Q2 2026 net income of $255.4 million and a net margin of 7.49%, down from 8.69% in Q3 2025 and 8.14% in Q4 2024. The gross margin for Q2 2026 was 91.2%, though this metric is less meaningful for financial firms where interest expenses are a primary cost; the operating margin was 35.69%, reflecting the impact of $911.7 million in interest expenses and $1.89 billion in operating expenses. The trailing twelve-month EPS of $0.058 appears anomalously low relative to quarterly EPS figures of $1.06 (Q2 2026), $0.72 (Q1 2026), and $0.89 (Q4 2025), suggesting the TTM figure may be distorted by non-recurring items or a data aggregation issue. Compared to typical investment banking margins, Jefferies' net margin of 7.49% is respectable but below the 15-20% range often seen at larger bulge-bracket firms, reflecting its middle-market focus and higher relative cost structure.
The balance sheet shows elevated leverage with a debt-to-equity ratio of 2.25, though this is typical for investment banks that use leverage to fund trading and underwriting activities. The current ratio of 2.43 indicates adequate short-term liquidity, and the firm generated $1.78 billion in trailing twelve-month free cash flow, demonstrating strong cash generation capacity. Return on equity stands at 6.72%, which is modest but positive, while return on assets is 1.18%, reflecting the capital-intensive nature of the business. The dividend yield of 3.05% with a payout ratio of 52.66% suggests a shareholder-friendly capital return policy, and the firm's ability to generate $1.59 billion in operating cash flow in Q2 2026 alone indicates it can fund growth internally without excessive reliance on external financing.
Quarterly Revenue
$2.2B
2026-08
Revenue YoY Growth
-23.6%
YoY Comparison
Gross Margin
91.3%
Latest Quarter
Free Cash Flow
$1.8B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is JEF Overvalued?
Given that Jefferies reported positive net income of $255.4 million in the most recent quarter and has a trailing twelve-month EPS of $0.058 (which appears distorted), the PE ratio is the primary valuation metric, with a trailing PE of 19.43x and a forward PE of 10.71x. The substantial gap between trailing and forward PE—a 44.9% decline—implies the market expects significant earnings growth in the coming year, likely driven by continued strength in investment banking revenues and operating leverage. The forward PE of 10.71x is notably low for a financial services firm, suggesting either undervaluation or skepticism about the sustainability of earnings growth.
Comparing Jefferies to the broader Financial Services sector, the stock trades at a price-to-book ratio of 1.16x and a price-to-sales ratio of 1.13x, which are relatively modest multiples. The sector average PE for capital markets firms typically ranges from 12x to 18x, placing Jefferies' trailing PE of 19.43x at a premium, but its forward PE of 10.71x represents a significant discount to the sector. The PEG ratio of -3.99 is negative due to the distorted trailing EPS, making it unreliable; however, the forward PE of 10.71x against estimated EPS growth suggests the stock may be undervalued if earnings materialize as expected. The price-to-book of 1.16x is below the sector average of 1.3-1.5x for investment banks, potentially reflecting concerns about return on equity, which at 6.72% lags the 10-12% typical for peers.
Historically, Jefferies' PE ratio has ranged from a low of 5.73x in Q3 2021 to a high of 40.56x in Q3 2023, with the current trailing PE of 19.43x sitting in the middle of that range. The price-to-book ratio of 1.16x is near the lower end of its historical band, which has ranged from 0.72x to 1.67x over the past five years, suggesting the stock is trading closer to historical lows on a book value basis. This could indicate a value opportunity if the firm can improve its return on equity, or it could signal fundamental deterioration if the market is pricing in lower future profitability. The price-to-sales ratio of 1.13x is also near the low end of its historical range of 3.36x to 5.93x, though this metric is less comparable due to changes in revenue composition over time.
PE
19.4x
Latest Quarter
vs. Historical
Mid-Range
5-Year PE Range 7x~31x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
20.7x
Enterprise Value Multiple
Investment Risk Disclosure
Jefferies faces significant financial and operational risks, primarily stemming from its elevated leverage and margin pressure. The debt-to-equity ratio of 2.25 is high, typical for investment banks but concerning given the firm's modest return on equity of 6.72%, which lags the 10-12% range of larger peers. Net margin has compressed to 7.49% in Q2 2026 from 8.69% in Q3 2025, despite a 36.74% year-over-year revenue increase, indicating that rising interest expenses ($911.7 million) and operating costs ($1.89 billion) are eroding profitability. Additionally, the trailing twelve-month EPS of $0.058 appears distorted, possibly due to non-recurring items, which complicates valuation and raises questions about earnings quality. The firm's reliance on investment banking revenue, which constituted $1.21 billion of Q2 2026 revenue, exposes it to cyclical downturns in M&A and capital markets activity, and any slowdown could disproportionately impact results given the high operating leverage.
Market and competitive risks are pronounced, with the stock trading at a premium trailing PE of 19.43x compared to the sector average of 12x-18x, though the forward PE of 10.71x suggests a discount if earnings materialize. The beta of 1.491 indicates the stock is 49% more volatile than the market, amplifying downside during market corrections; this is evident in the 1-month relative strength of -10.95% versus SPY. Competitive pressures from bulge-bracket firms and boutique advisory shops could limit Jefferies' ability to maintain its market share gains in the middle market, and regulatory headwinds, such as potential changes in capital requirements or trading regulations, could increase compliance costs. Recent news highlights broader market volatility, with TJX Companies and Palantir experiencing sharp declines due to valuation concerns, suggesting a risk-off environment that could disproportionately affect high-beta financials like Jefferies.
The worst-case scenario for Jefferies involves a combination of a sustained downturn in capital markets activity, margin compression worsening beyond current levels, and a breach of the 52-week low of $35.53. If investment banking revenues decline due to a freeze in M&A and underwriting, and interest expenses remain elevated, net income could fall sharply, leading to a compression of the forward PE multiple. In this scenario, the stock could retest its 52-week low of $35.53, representing a decline of approximately 25.5% from the current price of $47.68. A more severe outcome, such as a broader financial crisis, could push the stock toward its historical max drawdown of -48.81%, implying a price near $24.40, though this is less likely given the firm's diversified revenue base and strong cash flow generation of $1.78 billion TTM.
FAQ
The key risks for JEF are ranked as follows: 1) Financial risk from high leverage (debt-to-equity of 2.25) and margin compression (net margin down to 7.49% from 8.69% in Q3 2025), which could impair profitability if interest expenses remain elevated. 2) Market risk due to high beta (1.491) and severe relative underperformance (-44.90% vs. S&P 500 over one year), making the stock vulnerable to market downturns. 3) Competitive risk from larger bulge-bracket firms and boutique advisors, which could erode Jefferies' market share in the middle market and pressure revenues. 4) Company-specific risk related to the sustainability of its 36.74% revenue growth, as a slowdown in M&A and underwriting activity could lead to earnings misses and further analyst downgrades, as seen with UBS on June 18, 2026.
The 12-month forecast for JEF includes three scenarios: a bull case (25% probability) targeting $69.93-$76.00, driven by a capital markets rebound and margin expansion; a base case (55% probability) targeting $55.00-$62.00, assuming steady revenue growth and stable margins; and a bear case (20% probability) targeting $35.53-$46.00, reflecting a deal-making slowdown and margin deterioration. The base case is most likely, with the key assumption that revenue grows 15-20% year-over-year and net margin holds between 7% and 8%. The analyst average target of $59.50 aligns with the base case, implying a 24.8% upside from the current price of $47.68. However, the wide target range and recent downgrade highlight significant uncertainty, and the stock's high beta means outcomes could be amplified.
JEF appears undervalued on a forward-looking basis, with a forward PE of 10.71x compared to the sector average of 12x-18x and its own trailing PE of 19.43x. The price-to-book ratio of 1.16x is near the low end of its five-year range of 0.72x-1.67x and below the sector average of 1.3x-1.5x, suggesting the market is pricing in lower future returns. However, the trailing PE of 19.43x is at a premium to the sector, reflecting the distorted trailing EPS of $0.058. The valuation implies the market expects significant earnings growth, as evidenced by the estimated forward EPS of $5.04, but skepticism remains due to margin pressures and a 27.68% one-year price decline. If the company can achieve its earnings targets, the stock is undervalued; otherwise, it may be fairly valued or even overvalued given the risks.
From a risk/reward perspective, JEF presents a balanced proposition with a 24.8% upside to the analyst average target of $59.50, but also a 25.5% downside to the 52-week low of $35.53. The forward PE of 10.71x suggests undervaluation if earnings estimates of $5.04 are met, yet the trailing PE of 19.43x and net margin of 7.49% indicate current profitability challenges. The stock is a good buy for value investors with a long-term horizon who believe in the company's market share gains and can tolerate high volatility (beta 1.491). However, near-term risks such as margin compression and a recent UBS downgrade make it less suitable for risk-averse or short-term traders. A staggered accumulation strategy on dips toward $40-$45 could improve the risk/reward profile.
JEF is more suitable for long-term investment (minimum 2-3 years) given its cyclical business model, current margin pressures, and the need for a capital markets recovery to realize its earnings potential. The stock's high beta of 1.491 and 48.81% max drawdown indicate significant short-term volatility, making it risky for trading. The dividend yield of 3.05% and payout ratio of 52.66% provide some income support for patient investors, but the forward PE of 10.71x suggests the market is pricing in a multi-year earnings recovery. Short-term traders might exploit volatility around earnings, but the lack of near-term catalysts and the technical downtrend make timing difficult. A long-term horizon allows investors to benefit from Jefferies' market share gains and potential multiple expansion as margins improve.